Development of nonviral delivery systems is progressing toward a transfection efficiency sufficient to affect metabolic and neoplastic diseases in humans. Nevertheless, inadequate transfection efficiency of target cells with current nonviral systems still limits the utility of this therapy. In the current study, we have determined that a co-polymer of histidine and lysine (H-K) enhances the transfection efficiency of liposomes, a leading nonviral system. We found that in the absence of serum, the addition of this polymer increased transfection as much as 10-fold in comparison with the lipo-
Introduction
Successful in vivo gene therapy depends on the development of efficient, nontoxic gene delivery systems. Cationic liposomes are the most commonly used nonviral delivery system for delivery of plasmids into cells in vitro [1] [2] [3] and in vivo. [4] [5] [6] A significant problem associated with cationic liposomes is their low in vivo transfection efficiency, 7, 8 possibly due to inactivation of the liposomes by serum. 9, 10 Despite this limitation, cationic liposome carriers have several major advantages such as relative ease of large-scale production and minimal toxicity. 11 Thus, significant effort is presently being devoted to improving the in vivo efficacy of liposomes.
There have been several important developments which have enhanced liposome transfection efficiency. The discovery of new lipids, 12 the substitution of the helper lipid, cholesterol, for DOPE, 13 and steric stabilization with polyethylene glycol 14 have enhanced in vivo transfection efficiency of liposomes. The addition of polyl-lysine or protamine to cationic liposome carriers has also markedly enhanced the transfection efficiency of liposomes. 9, [15] [16] [17] [18] These highly basic polymers/proteins effectively condense the plasmid DNA whereas liposomes neutralize the remainder of the negative charge of the DNA and provide a scaffold for the polymer:DNA complex. In contrast to poly-l-lysine, cationic polymers such as polyamidoamine have been found not to increase the transfection efficiency of liposomes. Another approach to increase transfection efficiency of liposomes some:DNA complex alone. More impressively, the co-polymer in the presence of serum increased transfection efficiency up to 100-fold. Furthermore, in vivo expression of luciferase in a tumor increased 15-fold with the addition of H-K polymer to the liposome:plasmid DNA complexes. Without liposomes, the H-K polymer had little to no effect on transfection efficiency. We anticipate that further modifications of this co-polymer will yield molecules with both increased complexity and transfection efficiency. Gene Therapy (2000) 7, 1698-1705. or other cationic carriers is the addition of lysosomotropic agents to protect the plasmid from hydrolytic digestion within endosomes and/or enable its escape from endosomes. [19] [20] [21] [22] [23] [24] [25] [26] These lysosomotropic agents include chloroquine and bafilomycin A 1 , which are weak amines that buffer the pre-lysosomal vesicles.
Moreover, there are efficient gene delivery agents, which have DNA-condensing and pH buffering properties. [27] [28] [29] [30] These include polyethylenimine, Superfect, and polyamidoamine whose single repeating subunit contains both a positive charge and buffering capacity. Since binding and buffering properties within these polymers are fixed and cannot be varied, we believe that there is an inherent inflexibility of a polymer that has a single repeating subunit with two or more functional features. Furthermore, in those cases in which the structure of these polymers is known, it is likely that the polymers will not be metabolizable and with prolonged administration, these polymers may be toxic.
In this study, we designed a peptide bond-based copolymer to test its transfection potential when combined with cationic liposomes. The co-polymer is composed of lysine which complexes and partially neutralizes the negative charge of the plasmid DNA and histidine, which we hypothesize with a pKa of 6.0, will buffer and aid in the release of plasmid DNA from the pre-lysosomal vesicles. The cationic liposomes neutralize the remainder of the DNA charge and provide a scaffold for the polymer: DNA complex. Our results suggest that the H-K polymer significantly increases the transfection efficiency of liposomes both in vitro and in vivo.
Results
To investigate the effect of the co-polymer His-Lys (H-K) on transfection efficiency of a liposome:DNA complex, we examine several different concentrations of polymer, DNA and liposomes. The putative co-polymer:liposome:DNA complex was incubated with MDA-MB-435 breast cancer cells for 4 h in the absence of serum. Over a wide range of concentrations, we found that the copolymer of H-K enhanced the transfection efficiency of the liposome:PCI-luciferase (Luc) complex (Figure 1a ). The addition of the H-K co-polymer increased transfection efficiency of the liposome:PCI-Luc complex up to 10-fold compared with the liposome:PCI-Luc complex. The H-K polymer increased transfection efficiency of the liposome:PCI-Luc complex at all concentrations with an optimal amount added of 7.5 nmol. We observed no morphologic evidence of cellular toxicity due to the polymer even at concentrations of 0.5 mm. Without liposomes, we found that the H-K polymer was not an effective transfection carrier of PCI-Luc. In fact, luciferase expression was not detectable in most experiments when H-K polymer was the sole carrier (data not shown).
This enhancement of transfection efficiency by the H-K polymer was not limited to MDA-MB-435 cells. The H-K polymer increased transfection efficiency of liposome: DNA complexes in CHO (P Ͻ 0.0001, Student's t test) and NIH-3T3 (P Ͻ 0.02, Student's t test) cells as well (Figure 1b) . We then examined the effects of varying the length of the H-K co-polymer on transfection efficiency; a 13 mer, 19 mer, and 29 mer of the H-K polymer were examined. While all three polymers increased the transfection efficiency of the liposome:PCI-Luc complex (P Ͻ 0.05), the 19 and 29-length polymers increased transfection efficiency more than the 13 mer (P Ͻ 0.05, oneway ANOVA with Newman-Keuls procedure) (Figure 1c) .
Since serum frequently reduces the transfection efficiency of liposomes in vitro and in vivo, we examined the effect that medium containing serum had on the Gene Therapy H-K:liposome:DNA complexes. In the presence of serum, the co-polymer of H-K when added to the liposome:plasmid DNA complex had a 100-fold greater transfection efficiency than the liposome:PCI-Luc complexes alone (P Ͻ 0.002, Student's t test) (Figure 2a ). In contrast to liposome:PCI-Luc complexes, the transfection efficiency of the H-K:liposome:PCI-Luc complexes was less affected by serum. The enhancement of luciferase activity by the H-K polymer was corroborated with a plasmid encoding the green fluorescent protein (GFP). In the presence of serum, the H-K increased the percentage of MDA-MB-435 cells expressing GFP from less than 1% to approximately 25% (Figure 2b) . Furthermore, the H-K polymer:-liposome carrier enhanced transfection efficiency more than several commercially available cationic carriers (Table 1 ). More importantly, the H-K polymer markedly increased the transfection efficiency of these cationic liposomal carriers (P Ͻ 0.05, Student's t test).
Gene Therapy b The enhancement by H-K of transfection efficiency appears not to be simply due to enhanced condensation or binding of DNA with liposomes. In the absence of serum, the addition of H-K reduced the size of liposome:plasmid complexes modestly by 1.7-fold (188 nm to 110 nm). Furthermore, in the presence of serum, there were no significant differences between the H-K polymer:liposome:plasmid complexes (284 nm) and liposome:plasmid complexes (243 nm). We also investigated whether the H-K polymer increased DNA binding to liposomes. Interestingly, the H-K polymer increased the amount of DNA bound to liposomes from 1.5-to threefold in the absence or presence of serum (Figure 3 ). Preliminary evidence suggests that the histidine component of the H-K polymer may play a role in enhancing DNA binding to liposomes.
Figure 2 Co-polymer of H-K enhances transfection efficiency in the presence of serum. The H-K polymer:liposome:plasmid DNA complexes were prepared as described in the Materials and methods section. (a) After the H-K:liposome:PCI-Luc (ᮀ) and liposome:PCI-Luc () complexes were prepared, the complexes were diluted in either OptiM or OptiM with 10% serum and added to the cells for 4 h. Luciferase activity was measured 48 h later. H-K:liposome:PCI-Luc versus liposome:PCI-Luc without serum, P Ͻ 0.01; H-K:liposome:PCI-Luc versus liposome:PCI-Luc with serum, P Ͻ 0.002, Student's t test. (b) After H-K:liposome:PCI-GFP or liposome:PCI-GFP complexes were prepared, MDA-MB-435 cells were transfected in the presence of serum. Forty-eight hours after transfection, the cells were examined for GFP expression using a fluorescent microscope. A representative field is demonstrated for the H-K:liposome:PCI-GFP treated MDA-MB-435 cells. Most fields for the liposome:PCI-GFPtreated cells showed no fluorescence (×1000).
In order to determine whether the H-K co-polymer is physically linked to the liposome:DNA complex, we compared the effects on transfection efficiency by varying the order of addition of these three components. When the polymer was first incubated with the DNA, and then mixed with the liposomes, we observed the greatest enhancement of transfection efficiency (P Ͻ 0.05, oneway ANOVA with Newman-Keuls procedure) ( Figure 4 ). With all other mixing permutations, the transfection efficiency with H-K was reduced. The greatest reduction in transfection efficiency occurred when liposomes were first incubated with plasmid DNA, and later the polymer was added. Intermediate reductions in transfection occurred when the liposomes and polymer were simultaneously added to plasmid DNA. Similar results occurred with or without serum.
To investigate whether histidine enhances transfection efficiency, we substituted serine for histidine while maintaining the same number of lysines in this co-polymer. In the absence of serum, the K-S (lysine:serine) polymer enhanced the transfection efficiency slightly more than when no polymer was added. When compared with the H-K co-polymer, the K-S co-polymer was significantly less effective at increasing the transfection efficiency in the absence or presence of serum (Figure 5a ). In addition, compared to a poly-l-lysine polymer (19 mer) that has nearly twice as many lysines, the H-K polymer increased transfection efficiency in the absence and presence of serum by three and 50-fold, respectively (data not shown). Thus, although the lysine component of the copolymer enhances transfection (see H-S, Figure 5a ), probably by increasing DNA condensation and binding, it is evident that the histidine moiety of the polymer plays a significant role in increasing the transfection efficiency.
Since H-K is markedly more effective than the K-S (lysine:serine) co-polymer, the buffering capacity of histidine may have a significant role in augmenting the transfection efficiency of the H-K polymer. To determine if the buffering component of the H-K polymer increases transfection efficiency of liposome: plasmid complexes, we examined the effects of various lysosomotropic agents (chloroquine, bafilomycin A 1 ) on luciferase expression. Surprisingly, we found that incubation with bafilomycin A 1 or chloroquine significantly increased the transfection of the H-K:liposome:PCI-Luc triplex in NIH-3T3 and CHO cells. The enhancement with bafilomycin A 1 was particularly striking and increased the transfection efficiency of the triplex by five-fold (P Ͻ 0.002, Student's t test) (Figure 5b ). In contrast, bafilomycin A 1 did not enhance the transfection efficiency of the liposome:PCILuc complex in the absence of the H-K polymer. It is important to note that lysosomotropic agents did not universally enhance the transfection of the triplex in all cells examined. In MDA-MB-435 cells, neither bafilomycin nor chloroquine increased the transfection efficiency of the H-K:liposome:PCI-Luc triplex.
Since the H-K polymer enhanced in vitro transfection efficiency, we investigated the effect of the H-K polymer in vivo. After human breast cancer cells, which had been implanted into the mammary fat pad of nude mice, grew to palpable tumors, we injected either the H-K:liposome:
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Figure 5 (a) Comparison of H-K, K-S, and H-S co-polymers on transfection efficiency. After the polymer:liposome:PCI-Luc or liposome:PCI-Luc complexes were prepared, the complexes were added to the MDA-MB-435 cells for 4 h in the absence or presence of 10% serum. Forty-eight hours later, luciferase activity was measured. H-K versus K-S or H-S groups without serum, P Ͻ 0.01; H-K versus K-S or H-S groups with serum, P Ͻ 0.001, one-way ANOVA with Dunnett's procedure. (b) The effect of bafilomycin and the H-K polymer on luciferase expression in transfected CHO cells. After the H-K:liposome:PCI-Luc and liposome:PCI-Luc complexes were prepared, the complexes and 10 ng/ml of bafilomycin were added to the cells for 4 h. The cells were then washed, and luciferase activity was measured 48 h later. H-K:liposome:PCI-Luc with bafilomycin versus H-K:liposome:PCI-Luc, P Ͻ 0.002, Student's t test. In (a) and (b)
, the amounts of polymer, liposome, and plasmid DNA used to prepare the complexes were the same as described in Figure 1b. PCI-Luc or liposome:PCI-Luc complexes into tumors and compared expression of the luciferase reporter. A 15-fold enhancement of luciferase activity was observed in tumors injected with H-K:liposome:PCI-Luc compared to liposome:PCI-Luc (P Ͻ 0.02, Student's t test) (Figure 6a) . Similarly, H-K enhanced the gene and protein expression of green fluorescent protein (GFP). H-K:liposome:pEGFP-N1 complexes were injected into tumors whereas the contra-lateral tumors were injected with liposome:pEGFP-N1 complexes. GFP was detected by immunohistochemical methods and confirmed that the addition of H-K markedly enhanced protein expression (Figure 6b ).
Discussion
In this study, we demonstrated that the H-K polymer significantly increased transfection efficiency of liposomes both in vitro and in vivo. The enhancement of transfection Gene Therapy b
Figure 6 Increased in vivo gene expression with the H-K polymer. One week after injection of MDA-MB-435 cells bilaterally into the mammary fat pads of nude mice, and tumors were visibly present, complexes were injected into the tumors. (a) Luciferase activity. The liposome:PCI-Luc complex was injected into one tumor whereas the H-K:liposome:PCI-Luc complex was injected into the contralateral tumor. Twenty-four hours after injection, the luciferase values were measured. H-K:liposome:PCILuc versus liposome:PCI-Luc complexes, P Ͻ 0.002, Student's t test. (b) Immunohistochemical detection of GFP. Similar to luciferase experiments, tumors were injected with liposome:pEGFP-N1 or H-K:liposome:pEGFP-N1 complexes. Forty-eight hours after injection, the tumors were excised, fixed, and tissues stained with a rabbit polyclonal anti-GFP antibody as described in Materials and methods. A diaminobenzidene substrate was used to visualize antibody binding and is represented by a brown precipitate (×600).
efficiency by the H-K polymer was particularly marked in the presence of serum. In the absence of liposomes, we found that the low molecular weight H-K polymer was not an effective transfection carrier of PCI-Luc. Although large molecular weight histidylated poly-l-lysine polymers as transfection carriers were recently demonstrated to be more effective than poly-l-lysine as carriers, 31 these histidylated polymers enhanced transfection efficiency significantly less than polyethylenimine in most cells lines. In contrast, we found that the transfection efficiency of the H-K:liposome:PCI-luc triplex was at least 10-fold greater than polyethylenimine in the absence or presence of serum (data not shown). As a result, we expect that histidine-containing polymers will be most effective as carriers when used in combination with cationic liposomes.
To understand further the role of H-K in enhancing transfection efficiency of the liposomes, we determined if the order of mixing the three components affected transfection efficiency. These experiments suggest that the H-K polymer is physically associated with the liposome:PCI complex (Figure 4) . Unless the polymer is first mixed with the DNA, it appears that the low molecular weight polymer cannot compete adequately with the cationic liposomes for the negatively charged plasmid DNA. We also determined that pre-mixing the H-K polymer with serum did not enhance the transfection efficiency of the liposome:DNA complexes (data not shown). These findings suggest that the polymer is integrated into the liposome:DNA complex, and that the triplex is important for increased transfection efficiency.
There are several potential mechanisms that may explain why H-K enhances the transfection efficiency of the liposome:PCI-Luc complex. One explanation that may partly account for the increase in transfection efficiency by the H-K polymer is enhanced binding and/or condensation of DNA with liposomes. Cationic polymers such as protamine sulfate are known to enhance transfection efficiency by condensing and markedly reducing the size of DC-Chol liposome:DNA complexes. 17 The H-K polymer did not significantly affect the size of the liposome:DNA complexes. In the absence of serum, the H-K polymer reduced the size of DOTAP liposome:plasmid complexes by only 1.7-fold, whereas in the presence of serum, the H-K polymer did not affect the size of the liposome:DNA complex. Thus, the enhancement of transfection efficiency cannot be explained by the H-K polymer influencing the size of the liposome:DNA complexes. Furthermore, the minimal increase in the amount of DNA bound to liposomes due to H-K is unlikely to explain the marked enhancement in transfection efficiency (Figure 3 ).
An alternative mechanism by which the H-K polymer enhances transfection efficiency may be due to histidine's buffering capacity. Since the H-K polymer significantly enhances transfection more than the K-S polymer (Figure 5a) , it is evident that the histidine moiety plays an important role in enhancing transfection efficiency. As a result, we focused on examining the buffering capacity of the H-K polymer. Figure 5b suggests that synergism is occurring between the H-K component of the triplex and bafilomycin A 1 to increase transfection efficiency. Chloroquine, another lysosomotropic agent, was recently reported to enhance the transfection efficiency of low molecular weight polyethylenimine (PEI), a polymer that also buffers pre-lysosomal vesicles. 21 Transfection synergy between the low molecular weight PEI and chloroquine was thought to be due to partial buffering of the pre-lysosomal vesicles by PEI. In contrast, chloroquine did not increase the transfection efficiency of a large molecular weight PEI carrier, which more effectively buffers the pre-lysosomal vesicles. It appears that the low molecular H-K polymer, similar to the low molecular weight PEI, weakly buffers the pre-lysosomal vesicles allowing synergism with lysosomotropic agents to occur.
Although the lysine component of the H-K polymer appears to increase condensation and binding of DNA to liposomes, and the histidine component has a buffering effect on pre-lysosomal vesicles, we suspect that there are additional mechanisms of H-K that have an important role in the enhancement of transfection efficiency. For instance, preliminary results from our laboratory suggest that the addition of zinc increases the transfection efficiency of an analogue of the H-K polymer, perhaps by cross-linking the histidine components of the polymer. Other transitional metals present in the serum may also have a role in cross-linking the imidazole groups. By varying ratio and order of histidine and lysine amino acids within the polymer, we may enhance transfection efficiency and gain further understanding of the mechanisms of the H-K polymer.
We have previously used liposomes as carriers of antiangiogenic genes to inhibit tumor growth. 32 The expression of these secreted antiangiogenic proteins was quite low resulting in moderate reduction of tumor size. In this study, we determined that the combination of the H-K polymer with liposomes enhanced luciferase expression within the tumor 15-fold more than liposomes alone (Figure 6a) . Confirmation of enhanced delivery with the H-K polymer was demonstrated by immunohistochemical detection of GFP (Figure 6b ). We anticipate that the H-K:liposome carrier will augment the secretion and antitumor efficacy of these antiangiogenic proteins. Furthermore, the H-K polymer (or an H-K derivative) combined with liposomes or other carriers may have widespread applications in gene therapy.
Materials and methods
Cells A breast cancer cell line, MDA-MB-435, Chinese hamster ovary (CHO) and NIH-3T3 cells were maintained in DMEM containing 10% fetal calf serum and 20 mm glutamine.
Polymers
The biopolymer core facility at the University of Maryland synthesized the polymers on a Ranin Voyager synthesizer (PTI, Tucson, AZ, USA). The following polymers were made:
) H-S (19 mer)-S-H-S-H-S-H-S-H-S-G-S-H-S-H-S-H-S-H-S]; and (
The polymers were then purified on an HPLC (Beckman, Fullerton, CA, USA) and analyzed with mass spectroscopy (Perseptive Biosystems, Foster City, CA, USA) to verify the predicted molecular mass. The glycine inserted after every ninth amino acid significantly increased the yield and quality of the H-K polymer composed of 19 or more amino acids. Measurement of the S-K and H-K polymers with poly-l-lysine (Sigma, St Louis, MO, USA) used as a standard were done with 2,6-dinitro-4-trifluoromethylbenzenesulfonate (Pierce, Rockford, IL, USA) as previously described. 33, 34 Preparation of liposomes Preparation of the liposome:plasmid complexes have been previously described. 8, 32 In brief, DH5 bacteria (Life Technologies, Gaithersburg, MD, USA) containing the plasmids were grown in Superbroth to mid-log phase. The plasmids were then purified with Qiagen columns. An analytical gel of each plasmid (cut and uncut) was done to ensure that there was no contamination with other nucleic acids. Liposomes were composed of 1, 2-dioleoyl-3-trimethylammonium-propane (DOTAP) (Avanti, Birmingham, AL, USA). After hydration of the lipids, the liposomes were sonicated until clear with a Branson 1210 bath sonicator in the presence of argon. The liposomes were then extruded through 50 nm polycarbonate membranes with LipsoFast-Basic (Avestin, Ottawa, ON, Canada). The liposomes final concentration was 1 g/l. The transfection complex particle size was determined by the N4 Plus Submicron Particle Sizer (Coulter, Miami, FL, USA).
Several cationic liposomes were also purchased including lipofectamine (Life Technologies), DOTAP (Roche, Indianapolis, IN, USA), and (1,3-Di-oleoyloxy-2-(6-carboxy-spermyl)-propylamid (DOSPER; Roche).
In vitro transfection studies Cells (4.5 × 10 4 ) (MDA-MB-435, NIH3T3 or CHO) were initially plated into 24-well plates. After 48 h, when the cells were 60 and 80% confluent, cells were transfected with a plasmid encoding luciferase (PCI-Luc). In transfection experiments, the co-polymer was initially incubated with PCI-Luc for 30 min in OptiM. The amount of copolymer varied from 1.5 nmol to 15 nmol and plasmid DNA concentrations varied from 0.25 to 0.75 g of plasmid DNA. Cationic liposomes whose amounts ranged from 0.5 g (0.73 nmol) to 1.5 g (2.15 nmol) were then added, gently mixed, and then allowed to stand for an additional 30 min. Total volume for the polymer:liposome:DNA complex was 120 l. The polymer:liposome:DNA complex was then diluted with either 200 l of OptiM or OptiM + 15% serum. In experiments utilizing lysomotropic agents, either chloroquine (Sigma) or bafilomycin A 1 (Sigma) was added to the media at concentrations of 25 m and 10 ng/ml, respectively. Four hours after transfection, the complexes were removed and DMEM with 10% serum was added. 3 (except at the lower limits). In addition to the luciferase reporter plasmid, the MDA-MB-435 cells were transfected with a plasmid encoding GFP (PCI-GFP). After transfection, the expression of GFP was examined with an Olympus IMT-2 fluorescent microscope (Japan). Preparation and transfection conditions of PEI were done as previously described. 31 Duplicates were done for each concentration and each experiment was performed twice.
In vivo transfection
For in vivo studies, we injected bilaterally 3.0 × 10 5 MDA-MB-435 cells into the mammary fat pads of six nude mice. After tumors were palpable with no evidence of necrosis (range 30 to 50 mm 3 ), the complexes were injected into the tumors. The liposome:PCI-Luc complex was injected into one tumor and the H-K:liposome:PCI-Luc complex was injected into the contralateral tumor. The complexes
